CreatorDB | $47,000,000 | (Sep 17, 2025)
Vega(US) | $65,000,000 | (Sep 17, 2025)
Eve Security | $3,000,000 | (Sep 17, 2025)
Certified by Founder
Lodge
LoQus23 Therapeutics Ltd
start up
United Kingdom
- Cambridge, Cambridgeshire
- 02/10/2024
- Series A
- $46,550,175
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
- Industry Biotechnology Research
- Website https://loqus23.com/
- LinkedIn https://www.linkedin.com/company/loqus23-therapeutics-ltd/
Ethosphere | $2,500,000 | (Sep 17, 2025)
Trially AI | $4,700,000 | (Sep 17, 2025)
Bubo² | $2,000,000 | (Sep 17, 2025)
AllRock Bio | $50,000,000 | (Sep 17, 2025)
Overmind | $6,000,000 | (Sep 17, 2025)
BIOWEG | $18,970,160 | (Sep 17, 2025)
Plumerai | $8,700,000 | (Sep 17, 2025)
Hiverge | $5,000,000 | (Sep 17, 2025)
uiAgent | $4,600,000 | (Sep 16, 2025)